Drawing for DIMETACHOL

USPTO serial 77680712

DIMETACHOL

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SEVERSON, KAREN
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with DIMETACHOL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Anti-diabetic pharmaceuticals; Cardiovascular pharmaceuticals; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti- infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in chemotherapy; Pharmaceuticals, namely, lipid lowering agents; Plant extracts for medical, veterinary and pharmaceutical purposesABANDONED—
042Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticalsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 31, 2009MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Aug 31, 2009ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Aug 31, 2009OP.TOPPOSITION TERMINATED NO. 999999—
Aug 31, 2009OP.SOPPOSITION SUSTAINED NO. 999999—
Aug 20, 2009EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Aug 20, 2009OP.IOPPOSITION INSTITUTED NO. 999999—
Jul 17, 2009ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jun 23, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 3, 2009NPUBNOTICE OF PUBLICATION—
May 21, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 21, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 21, 2009DOCKASSIGNED TO EXAMINER—
Mar 9, 2009AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Mar 9, 2009ALIEASSIGNED TO LIE—
Mar 6, 2009PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Mar 4, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 4, 2009NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance